Delpharm Tours is a finished-dose manufacturer based in France. It appears in 6 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), MINSA (CR) and ARCSA (EC). Its GMP standing is certified by ANSM (FR), EMA and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 11 June 2021 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Chambray Les Tours, United Arab Emirates | Not on file |
| CHAMBRAY-LÈS-TOURS, France | Not on file |
| France, France | 3008349307 |
| Chambray Les Tours, France | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 2 | None |
| MINSA (CR) | 2 | None |
| ARCSA (EC) | 1 | None |
| NPRA (MY) | 1 | None |
| ANSM (FR) | None | 16 |
| EMA | None | 2 |
| ANVISA (Brazil) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $40.6M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Delpharm Tours comes back tiered against every other supplier able to file there.
Start for free